[Primary prevention of variceal bleeding in cirrhosis].
Schepke
M
M
Medizinische Universitätsklinik und Poliklinik I, Bonn. Michael.Schepke@ukb.uni-bonn.de
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000628:therapy; D004945:Esophagoscopy; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000628:therapy; D008026:Ligation; D008103:Liver Cirrhosis / Q000150:complications* / Q000628:therapy; D018570:Risk Assessment; D015911:Sclerotherapy
D000319:Adrenergic beta-Antagonists